SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

被引:477
作者
Wald, D
Qin, JZ
Zhao, ZD
Qian, YC
Naramura, M
Tian, LP
Towne, J
Sims, JE
Stark, GR
Li, XX
机构
[1] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA
[2] Amgen Corp, Seattle, WA 98101 USA
关键词
D O I
10.1038/ni968
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Toll-like receptor-interleukin 1 receptor signaling (TLR-IL-1R) receptor superfamily is important in differentially recognizing pathogen products and eliciting appropriate immune responses. These receptors alter gene expression, mainly through the activation of nuclear factor-kappaB and activating protein 1. SIGIRR (single immunoglobulin IL-1R-related molecule), a member of this family that does not activate these factors, instead negatively modulates immune responses. Inflammation is enhanced in SIGIRR-deficient mice, as shown by their enhanced chemokine induction after IL-1 injection and reduced threshold for lethal endotoxin challenge. Cells from SIGIRR-deficient mice showed enhanced activation in response to either IL-1 or certain Toll ligands. Finally, biochemical analysis indicated that SIGIRR binds to the TLR-IL-1R signaling components in a ligand-dependent way. Our data show that SIGIRR functions as a biologically important modulator of TLR-IL-1R signaling.
引用
收藏
页码:920 / 927
页数:8
相关论文
共 36 条
  • [1] The role of IL-18 in innate immunity
    Akira, S
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) : 59 - 63
  • [2] Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
    Alexopoulou, L
    Holt, AC
    Medzhitov, R
    Flavell, RA
    [J]. NATURE, 2001, 413 (6857) : 732 - 738
  • [3] Inflammatory bowel disease: new insights into pathogenesis and treatment
    Ardizzone, S
    Porro, GB
    [J]. JOURNAL OF INTERNAL MEDICINE, 2002, 252 (06) : 475 - 496
  • [4] Bingham CO, 2002, J RHEUMATOL, V29, P3
  • [5] Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4
    Burns, K
    Janssens, S
    Brissoni, B
    Olivos, N
    Beyaert, R
    Tschopp, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) : 263 - 268
  • [6] MyD88, an adapter protein involved in interleukin-1 signaling
    Burns, K
    Martinon, F
    Esslinger, C
    Pahl, H
    Schneider, P
    Bodmer, JL
    Di Marco, F
    French, L
    Tschopp, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) : 12203 - 12209
  • [7] TARF6 is a signal transducer for interleukin-1
    Cao, ZD
    Xiong, J
    Takeuchi, M
    Kurama, T
    Goeddel, DV
    [J]. NATURE, 1996, 383 (6599) : 443 - 446
  • [8] IRAK: A kinase associated with the interleukin-1 receptor
    Cao, ZD
    Henzel, WJ
    Gao, XO
    [J]. SCIENCE, 1996, 271 (5252) : 1128 - 1131
  • [9] INTERLEUKIN-1
    DINARELLO, CA
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1984, 6 (01): : 51 - 95
  • [10] Dunne A, 2003, SCI STKE, V2003, pre3, DOI DOI 10.1126/STKE.2003.171.RE3